DNAJC9-AS1

Across TCGA pan-cancer cohorts, DNAJC9-AS1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated DNAJC9-AS1 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher DNAJC9-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated DNAJC9-AS1 expression acts as an unfavorable survival marker, although some lineages such as CESC and SKCM show a favorable association.

CESC, SKCM, and PAAD are the cancer types where DNAJC9-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Quartile	All	0.889	0.699	.002	52	view →
SKCM	OS	Quartile	III,IV	0.802	0.595	.005	36	view →
PAAD	OS	Quartile	All	0.685	0.266	<.001	33	view →
KIRC	DFS	Tertile	III,IV	0.326	0.542	.004	24	view →
READ	OS	Median	III,IV	0.724	0.255	<.001	24	view →
OV	DFS	Median	All	0.590	0.495	.005	20	view →
KIRP	OS	Tertile	All	0.975	0.883	.007	19	view →
HNSC	OS	Tertile	All	0.810	0.701	.007	16	view →
MESO	OS	Median	II,III,IV	0.687	0.439	.011	12	view →
BRCA	OS	Quartile	III,IV	0.984	0.879	.010	12	view →
PRAD	DFS	Median	All	0.669	0.872	.007	12	view →
LGG	DFS	Quartile	All	0.756	0.837	.012	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

DNAJC9-AS1–CESC (OS)

Open the CESC breakdown →